HEYL and neoplasm: Thus, thanks to the high sensitivity of Well-TEMP-seq, we can provide insights into the 5-AZA-CdR induced anti-tumor response of STAT1, HEYL, and PITX1 TFs activation in the early stage of treatment (e.g., in the first three days), which has not been unveiled before.